Results 121 to 130 of about 414,372 (151)

Improved pregnancy outcome in gestational diabetes mellitus patients treated with insulin aspart and metformin: a comparative study. [PDF]

Am J Transl Res
Fan X, Wang C, Chen L, Zhao X, Wu Y, Zeng G.   +5 more
europepmc   +1 more source

Effectiveness of Faster Aspart versus Insulin Aspart in Children with Type 1 Diabetes: A Meta-Analysis. [PDF]

Iran J Public Health
Wei J, Wang Y.
europepmc   +1 more source

Insulin aspart plus high-dose vitamin D supplementation for gestational diabetes mellitus: analysis of efficacy and risk factors for maternal and infant outcomes. [PDF]

Am J Transl Res
Qiu H, Li J, Chen C, Xiao F.
europepmc   +1 more source

Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing. [PDF]

Diabetes Ther
Wu Y, Zhang J, Li A.
europepmc   +1 more source

Estimated Cost-effectiveness of Subcutaneous Insulin Aspart in the Management of Mild Diabetic Ketoacidosis Among Children.

JAMA Netw Open, 2022
Bali IA, Al-Jelaify MR, AlRuthia Y, Mulla JZ, Amlih DF, Bin Omair AI, Al Khalifah RA.   +6 more
europepmc   +1 more source

Comparative physicochemical and structural characterisation studies establish high biosimilarity between BGL-ASP and reference insulin aspart. [PDF]

Sci Rep
Ghade NS, Thappa DK, Lona J, Krishnan AR, Sonar SM.   +4 more
europepmc   +1 more source

Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus.

Evid Based Complement Alternat Med, 2022
Jin H, Zhang H.
europepmc   +1 more source

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study. [PDF]

J ASEAN Fed Endocr Soc
Nicodemus N, Ang-Golangco N, Aquitania G, Ardeña GJR, Dampil OA, Fernando RE, Flor NT, Kho S, Mirasol R, Panelo A, Pasaporte F, Puno-Rocamora M, Shoeb A, Tolentino M.   +13 more
europepmc   +1 more source

Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study. [PDF]

J Family Med Prim Care
Baruah MP, Aneja P, Pitale S, Bhograj A, Agrawala RK, Aggarwal A, Mahadev PG, Madhavdas DC, Shah S, John M, Pathan MKA, Revanna M, Chandrappa M, Singh KP.   +13 more
europepmc   +1 more source

Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid^® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study. [PDF]

Res Pharm Sci
Dongre SA, Kulkarni GA, Mishra A, Deshmane RB, Sonar N, Yashi K, Thapa D, Ghade N, Kadoo SM, Krishnan AR, Sonar SM.   +10 more
europepmc   +1 more source